Browsing by Author "Sarita Bajaj"

Now showing 1 - 6 of 6

Chronic complications in newly diagnosed patients with Type 2 diabetes mellitus in India
(Medknow Publications, 2014) Aravind Sosale; K. Prasanna Kumar; S. Sadikot; Anant Nigam; Sarita Bajaj; A. Zargar; S. Singh
Background: Prevalence of diabetes is on an increase in India, currently there is limited nation-wide data regarding the prevalence of chronic complications in diabetic patients at diagnosis. This information will help health-care professionals approach management more aggressively to prevent complications. Objective: To determine the prevalence of chronic complications in newly-diagnosed Type 2 diabetic (T2D) patients in India. Design and Methods: This was a cross-sectional survey of T2D patients, diagnosed within 3 months of their first visit to the centers doing the survey. Each patient was screened for diabetic complications, hypertension, dyslipidemia, and body mass index. Family history was recorded. Standard protocols were used to make the diagnosis of retinopathy, neuropathy and nephropathy. Data analysis was carried out using the standard statistical techniques. Results: Of the total 4,600 (males 67%, females 33%) newly diagnosed patients with T2D, majority were from the age group 41-50 years (40%). 13.15% of newly detected India T2D had neuropathy 6.1% had retinopathy and 1.06% had nephropathy. Risk factors of macro vascular complication such as hypertension, obesity, and dyslipidemia were observed in 23.3%, 26%, and 27% of patients respectively. Ischemic heart disease was noticed in 6%. Conclusion: High prevalence of micro vascular complications was present at diagnosis along with association of CV cardiovascular risk factors among Indian T2D. In view of this, screening must be instituted for all diabetics for complications at the time of diagnosis itself.
Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes
(Elsevier Ltd, 2017) Sujoy Ghosh; A.G. Unnikrishnan; Banshi Saboo; Jothydev Kesavadev; S.R. Aravind; Sarita Bajaj; Rajesh Rajput; Krishna Seshadri; Narsingh Verma; Arvind Gupta; Brij Mohan Makkar; Mihir Saikia; Shailaja Kale; Suresh Damodaran; Ashish Dengra; T.K.M. Eashwar; Anuj Maheshwari; Sharad Pendsey; Sanjeev R. Phatak; Surendra Kumar Sharma; Surya Kumar Singh; A. Ramachandran; Abdul H. Zargar; Shashank R. Joshi; Shaukat M. Sadikot
Over the time due to progressive nature of diabetes, proactive intensification of the existing insulin therapy becomes imminent as it minimizes patients’ exposure to chronic hypo/hyperglycaemia and reduces weight gain while achieving individualized glycaemic targets. This review focuses on the strength of evidence behind various options for intensification, primarily the insulins as also the GLP-1 analogues. The recommendations presented here are meant to serve as a guide for the physician managing type 2 diabetes patients requiring insulin intensification upon failing of basal insulin therapy. © 2017 Diabetes India
Fasts, feasts and festivals in diabetes-1: Glycemic management during Hindu fasts
(Medknow Publications, 2015) Sanjay Kalra; Sarita Bajaj; Yashdeep Gupta; Pankaj Agarwal; S. Singh; Sandeep Julka; Rajeev Chawla; Navneet Agrawal
This communication is the first of a series on South Asian fasts, festivals, and diabetes, designed to spread awareness and stimulate research on this aspect of diabetes and metabolic care. It describes the various fasts observed as part of Hindu religion and offers a classification scheme for them, labeling them as infrequent and frequent. The infrequent fasts are further sub-classified as brief and prolonged, to facilitate a scientific approach to glycemic management during these fasts. Pre-fast counseling, non-pharmacological therapy, pharmacological modification, and post-fast debriefing are discussed in detail. All available drug classes and molecules are covered in this article, which provides guidance about necessary changes in dosage and timing of administration. While in no way exhaustive, the brief review offers a basic framework which diabetes care professionals can use to counsel and manage persons in their care who wish to observe various Hindu fasts.
Uttar pradesh association of physicians of India position statement: Betel quid (paan) and diabetes
(Journal of Association of Physicians of India, 2018) Yatan Pal Singh Balhara; Sanjay Kalra; Sarita Bajaj; Pooja Patnaik Kuppili; D. Himanshu; Veerendra Atam; Kauser Usman; Veerendra Singh; Shyam Chand Chaudhary; S. Chakravorty; Anupam Wakhlu; Jalees Fatma; Sanjay Tandon; Anuj Maheshwari; Abha Gupta; Anjum Parvez; Jaya Chakravarty; R.R. Chaudhary; A.K. Singh; K.K. Sawlani; Manoj Mathur; N.K. Soni; Om Kumari Gupta; Madhukar Rai; Sudhir Agarwal
Betel quid (paan) chewing is common in India, especially in Uttar Pradesh. Betel quid has multifaceted relationship with health, including metabolic and psychosocial health. The current recommendations have been released keeping in view the public health and clinical importance of this addictive behavior. The objective of this document is to offer clinical guidance for screening, diagnosis and management of co-occurring betel quid chewing among persons with Diabetes Mellitus (DM). The document aims to provide education and guidance to clinicians engaged in care and management of persons with DM, and improve access to treatment for co-occurring betel quid chewing among persons with DM. The current recommendation grades are based on published evidence, and categorized as strong, intermediate, weak and no evidence. The strength of these recommendations is based on the level of evidence. © 2018, Journal of Association of Physicians of India. All rights reserved.
Uttar Pradesh Association of Physicians of India Position Statement: Betel Quid (Paan) and Diabetes
(NLM (Medline), 2018) Yatan Pal Singh Balhara; Sanjay Kalra; Sarita Bajaj; Pooja Patnaik Kuppili; D. Himanshu; Veerendra Atam; Kauser Usman; Kauser Usman; Veerendra Singh; Shyam Chand Chaudhary; S. Chakravorty; Anupam Wakhlu; Jalees Fatma; Sanjay Tandon; Anuj Maheshwari; Abha Gupta; Anjum Parvez; Jaya Chakravarty; R.R. Chaudhary; A.K. Singh; K.K. Sawlani; Manoj Mathur; N.K. Soni; Om Kumari Gupta; Madhukar Gupta; Sudhir Agarwal
Betel quid (paan) chewing is common in India, especially in Uttar Pradesh. Betel quid has multifaceted relationship with health, including metabolic and psychosocial health. The current recommendations have been released keeping in view the public health and clinical importance of this addictive behavior. The objective of this document is to offer clinical guidance for screening, diagnosis and management of co-occurring betel quid chewing among persons with Diabetes Mellitus (DM). The document aims to provide education and guidance to clinicians engaged in care and management of persons with DM, and improve access to treatment for co-occurring betel quid chewing among persons with DM. The current recommendation grades are based on published evidence, and categorized as strong, intermediate, weak and no evidence. The strength of these recommendations is based on the level of evidence. © Journal of the Association of Physicians of India 2011.
Uttar Pradesh association of physicians of India position statement: Tobacco use and metabolic syndrome
(Journal of Association of Physicians of India, 2017) Yatan Pal Singh Balhara; Sanjay Kalra; Sarita Bajaj; Pooja Patnaik Kuppili; D. Himanshu; Veerendra Atam; Kauser Usman; Veerendra Singh; Shyam Chand Chaudhary; S. Chakravorty; Anupam Wakhlu; Jalees Fatma; Sanjay Tandon; Anuj Maheshwari; Abha Gupta; Anjum Parvez; Jaya Chakravarty; R.R. Chaudhary; A.K. Singh; K.K. Sawlani; Manoj Mathur; N.K. Soni; Om Kumari Gupta; Madhukar Rai; Sudhir Agarwal
Tobacco use is one of the main preventable causes of mortality and morbidity worldwide. The global disease burden due to tobacco use is huge with projected mortality of eight million lives per year by 2030. Metabolic syndrome (MS) is defined as a constellation of cardiovascular and endocrine risk factors such as insulin resistance, obesity, raised blood pressure, and abnormal lipid profile. The relationship between tobacco use and MS has been well established. Also, the causal association between tobacco use and development of individual components of MS is well established. The Uttar Pradesh Association of Physicians of India (UP API) has drafted this position statement on managing tobacco use among persons with or at risk of developing Metabolic Syndrome (MS). This position statement presents evidence-based recommendations as described below. Scope and purpose The objective of this position statement is to offer clinical recommendations for screening, diagnosis and management of tobacco use among persons with or at risk of developing Metabolic Syndrome (MS). The purpose of this document is to aid in identification and treatment of maladaptive patterns of tobacco use i.e. tobacco use disorder (tobacco dependence, harmful use, abuse) in person with or at risk of developing MS. Intended Audience The position statement is targeted at the clinicians engaged in care and management of person with or at risk of developing Metabolic Syndrome (MS). This might also be of relevance to the policy makers considering the public health burden of both MS and tobacco use disorders. © 2017, Journal of Association of Physicians of India. All rights reserved.